↓ Skip to main content

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Overview of attention for article published in Investigational New Drugs, July 2018
Altmetric Badge

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
60 Mendeley